Cargando…

Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study

BACKGROUND: The tyrosine kinase inhibitor pazopanib is used for treatment of sarcoma. Recent studies have suggested that the use of pazopanib may lead to the development of pneumothorax, an unexpected adverse effect in patients with sarcoma metastatic to the chest. METHODS: We conducted a retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sabath, Bruce, Muhammad, Hasan A, Balagani, Amulya, Ost, David E, Vakil, Erik, Ahmed, Tahreem, Vial, Macarena R, Grosu, Horiana B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167904/ https://www.ncbi.nlm.nih.gov/pubmed/30285733 http://dx.doi.org/10.1186/s12885-018-4858-8

Ejemplares similares

Tension Pneumothorax: Is it Sarcoma or Pazopanib?
por: Sebanayagam, Vinoja, et al.
Publicado: (2020)

Combined pleuroscopy and endobronchial ultrasound for diagnosis and staging of suspected lung cancer
por: Vial, Macarena R., et al.
Publicado: (2017)

Bilateral spontaneous pneumothorax and massive pneumomediastinum under Pazopanib therapy
por: Leuzzi, Giovanni, et al.
Publicado: (2015)

Control of bleeding from intercostal artery laceration
por: Sabath, Bruce F., et al.
Publicado: (2022)

Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature
por: Nakahara, Yoshiro, et al.
Publicado: (2017)

Spontaneous secondary pneumothorax with concomitant malignant pericardial effusion in the context of metastatic synovial sarcoma
por: Karapanos, Lewis, et al.
Publicado: (2023)

Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series
por: Verschoor, Arie J, et al.
Publicado: (2014)

Pazopanib: Approval for Soft-Tissue Sarcoma
por: Nguyen, Diana T., et al.
Publicado: (2013)

Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel, Pierre, et al.
Publicado: (2012)

Pazopanib in advanced soft tissue sarcomas
por: Lee, Alex T. J., et al.
Publicado: (2019)

Clinical Risk Factors for Death in Patients With Empyema and Active Malignancy
por: Salahuddin, Moiz, et al.
Publicado: (2023)

Epithelioid sarcoma with spontaneous pneumothorax and massive pleural effusion
por: Jeon, So-Yeon, et al.
Publicado: (2016)

Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis
por: Nakano, Kenji, et al.
Publicado: (2016)

Pazopanib radio-sensitization of human sarcoma tumors
por: Wang, Feng, et al.
Publicado: (2018)

Pazopanib in the management of advanced soft tissue sarcomas
por: Cranmer, Lee D, et al.
Publicado: (2016)

Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience()
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2019)

Location of Ruptured Bullae in Secondary Spontaneous Pneumothorax
por: Choi, Jinseok, et al.
Publicado: (2017)

Secondary Spontaneous Pneumothorax Mimicking Lung Herniation
por: Walker, Brandon L, et al.
Publicado: (2020)

Radiologically Guided Management of Secondary Spontaneous Pneumothorax
por: Aljehani, Yasser, et al.
Publicado: (2020)

Silicosis With Secondary Spontaneous Pneumothorax in the Western Rajasthan
por: Meena, Manish Kumar, et al.
Publicado: (2020)

Secondary Spontaneous Pneumothorax Caused by Pulmonary Schistosomiasis
por: Bamefleh, Hanaa, et al.
Publicado: (2021)

Chemotherapy Associated Bilateral Secondary Spontaneous Pneumothorax
por: Singh, Randeep, et al.
Publicado: (2022)

Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents
por: Datar, Saumil, et al.
Publicado: (2020)

Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis
por: Aiba, Hisaki, et al.
Publicado: (2021)

Spontaneous pneumothorax or no pneumothorax at all?
por: Burger, Barrett J., et al.
Publicado: (2023)

Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing Sarcoma
por: Attia, Steven, et al.
Publicado: (2015)

The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with Pazopanib
por: Mori, Yoshinori, et al.
Publicado: (2018)

Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
por: Shah, Pooja, et al.
Publicado: (2020)

Pazopanib in rare histologies of metastatic soft tissue sarcoma
por: Kataria, Babita, et al.
Publicado: (2021)

Spindle cell sarcoma: a rare cause of a spontaneous pneumothorax
por: Pedroso, Ana, et al.
Publicado: (2021)

Partial ambulatory management of severe secondary spontaneous pneumothorax
por: Masih, Izhaq, et al.
Publicado: (2017)

Spontaneous pneumothorax secondary to chronic cavitary pulmonary histoplasmosis
por: Geurkink, Samuel, et al.
Publicado: (2020)

Secondary spontaneous pneumothorax as post-COVID-19 sequela
por: Jain, Moli Jai, et al.
Publicado: (2021)

Morbidity, mortality, and surgical treatment of secondary spontaneous pneumothorax
por: Değirmenci, Mehmet
Publicado: (2023)

Advanced Alveolar Soft Part Sarcoma Treated with Pazopanib over Three Years
por: Shido, Yoji, et al.
Publicado: (2017)

Spontaneous pneumothorax
por: Matthys, Heinrich
Publicado: (2011)

Spontaneous Pneumothorax
por: Jones, W. G.
Publicado: (1940)

Spontaneous Pneumothorax
por: Viswanathan, R.
Publicado: (1934)

Safety and efficacy of ambulatory management of secondary spontaneous pneumothorax: a case series
por: Khan, Fasih, et al.
Publicado: (2019)

Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders
por: Nakano, Kenji, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cobvvbipak4bki0nr76ktjomql